Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia

Epidemiology and Infection

Volumn 124, Issue 3, 2000, Pages 467-479

  Cutts, F T ^a   Abebe, A ^b   Messele, T ^b   Dejene, A ^b   Enquselassie, F ^c,d   Nigatu, W ^b   Nokes, D J ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA ANTIBODY;

ADOLESCENT; AGE; ARTICLE; CHILD; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; ETHIOPIA; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PUBLIC HEALTH; RUBELLA; RUBELLA VIRUS; SEROEPIDEMIOLOGY; SEROPREVALENCE; URBAN POPULATION; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; ETHIOPIA; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE;

EID: 0033870659     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899003532     Document Type: Article

References (35)

1. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: Burden of disease from CRS
2. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 2: Vaccination against rubella
3. The eradication of rubella
4. Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
5. Methods of assessing the impact of congenital rubella infection
6. Rubella epidemiology in South East England
7. Modelling the incidence of congenital rubella syndrome in developing countries
8. Age- and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia
9. A simplified general method for cluster-sample surveys of health in developing countries
10. A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia
11. Modelling forces of infection for measles, mumps and rubella
12. The estimation of age-related rates of infection from case notifications and serological data
13. Modelling toxoplasma incidence from longitudinal seroprevalence in pregnant women in Stockholm, Sweden
14. The force of measles infection in East Africa
15. A catalytic model of infection for measles
16. Vaccination against rubella and measles: Quantitative investigations of different policies
17. Methods for estimating the incidence of primary infection in pregnancy: A reappraisal of toxoplasmosis and cytomegalovirus data
18. Rubella seroepidemiology in a non-immunized population of Sao Paulo State, Brazil
19. Statistical models in epidemiology
20. Consequences of confirmed maternal rubella at successive stages of pregnancy
21. Infectious diseases of humans: Dynamics and control
22. Measles in developing countries. Part I. Epidemiological parameters and patterns
23. Modelling vaccination programmes
24. Herd immunity: History, theory, practice
25. A model-based design of a vaccination strategy against rubella in a non-immunized community of Sao Paulo state, Brazil
26. La seroepidemiologia de la rubeola en Mexico: Datos y teoria
27. WHO collaborative study on the sero-epidemiology of rubella in Caribbean and middle and south American populations in 1968
28. Sero-epidemiology of rubella in Imo state of Nigeria
29. Rubella immunity: Defining the level of protective antibody
30. Rubella vaccines and the immunity gap
31. How well do low levels of rubella antibody protect
32. Rubella Vaccination and congenital rubella syndrome in western Australia
33. Surveillance of antibody to measles, mumps, and rubella by age